Literature DB >> 9533933

Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation.

D Stelts1, R W Egan, A Falcone, C G Garlisi, G J Gleich, W Kreutner, T T Kung, D K Nahrebne, R W Chapman, M Minnicozzi.   

Abstract

Accumulation of eosinophils in the lung with concomitant tissue damage are defining histopathologic features of human asthma. Through degranulation and the release of proinflammatory proteins such as major basic protein (MBP), eosinophils may perpetuate this inflammatory response. We investigated the extent of eosinophil degranulation in a murine model of allergic pulmonary inflammation. In this paradigm, the mice develop pulmonary eosinophilia, mucus hypersecretion, tissue damage, and airway edema and hyperreactivity. To evaluate the degree of eosinophil degranulation, we used a polyclonal antibody to murine MBP (mMBP) to perform dot blot analysis of bronchoalveolar lavage (BAL) cells and fluids, and immunohistochemical fluorescent analysis of lung tissue sections. After ovalbumin antigen challenge, we were unable to detect immunoreactive mMBP in the BAL fluids from either nonsensitized or sensitized mice. However, after lysis of the recoverable BAL cells, we were able to detect mMBP by immunoblot analysis, with the levels of immunoreactive mMBP directly related to the number of recoverable eosinophils. We also examined paraffin-embedded, lung tissue sections for patterns of mMBP deposition. Whereas lung sections from allergic mice revealed prominent peribronchial eosinophilia after antigen challenge, tissue sections from nonsensitized animals rarely displayed eosinophils. Despite the presence of numerous eosinophils, no immunohistologic evidence of extracellular mMBP could be found in antigen-challenged allergic mice. Furthermore, rechallenged allergic mice displayed a significant increase in the number of recruited pulmonary eosinophils but all immunoreactive mMBP was still intracellular. We conclude that the recruited pulmonary eosinophils have not substantially degranulated. These results suggest that, in this murine model of allergic inflammation, eosinophil degranulation and release of mMBP does not contribute to the observed pulmonary inflammation and airway hyperreactivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533933     DOI: 10.1165/ajrcmb.18.4.2957

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  14 in total

Review 1.  Eosinophil crystalloid granules: structure, function, and beyond.

Authors:  Valdirene S Muniz; Peter F Weller; Josiane S Neves
Journal:  J Leukoc Biol       Date:  2012-06-06       Impact factor: 4.962

2.  The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease.

Authors:  Sergei I Ochkur; John Dongil Kim; Cheryl A Protheroe; Dana Colbert; Redwan Moqbel; Paige Lacy; James J Lee; Nancy A Lee
Journal:  J Immunol Methods       Date:  2011-10-12       Impact factor: 2.303

3.  Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation.

Authors:  Elizabeth A Jacobsen; Sergei I Ochkur; Alfred D Doyle; William E LeSuer; Wen Li; Cheryl A Protheroe; Dana Colbert; Katie R Zellner; HuaHao H Shen; Charles G Irvin; James J Lee; Nancy A Lee
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

4.  Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications.

Authors:  Njira Lugogo; Dave Francisco; Kenneth J Addison; Akarsh Manne; William Pederson; Jennifer L Ingram; Cynthia L Green; Benjamin T Suratt; James J Lee; Mary E Sunday; Monica Kraft; Julie G Ledford
Journal:  J Allergy Clin Immunol       Date:  2017-06-15       Impact factor: 10.793

5.  B-cell deficiency suppresses vaccine-induced protection against murine filariasis but does not increase the recovery rate for primary infection.

Authors:  C Martin; M Saeftel; P N Vuong; S Babayan; K Fischer; O Bain; A Hoerauf
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules.

Authors:  Revital Shamri; Rossana C N Melo; Kristen M Young; Maytal Bivas-Benita; Jason J Xenakis; Lisa A Spencer; Peter F Weller
Journal:  FASEB J       Date:  2012-01-31       Impact factor: 5.191

7.  Intranasal curcumin protects against LPS-induced airway remodeling by modulating toll-like receptor-4 (TLR-4) and matrixmetalloproteinase-9 (MMP-9) expression via affecting MAP kinases in mouse model.

Authors:  Asha Kumari; D K Singh; D Dash; Rashmi Singh
Journal:  Inflammopharmacology       Date:  2018-11-23       Impact factor: 4.473

Review 8.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".

Authors:  James J Lee; Elizabeth A Jacobsen; Sergei I Ochkur; Michael P McGarry; Rachel M Condjella; Alfred D Doyle; Huijun Luo; Katie R Zellner; Cheryl A Protheroe; Lian Willetts; William E Lesuer; Dana C Colbert; Richard A Helmers; Paige Lacy; Redwan Moqbel; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

9.  Frontline Science: Eosinophil-deficient MBP-1 and EPX double-knockout mice link pulmonary remodeling and airway dysfunction with type 2 inflammation.

Authors:  Sergei I Ochkur; Alfred D Doyle; Elizabeth A Jacobsen; William E LeSuer; Wen Li; Cheryl A Protheroe; Katie R Zellner; Dana Colbert; HuaHao H Shen; Charlie G Irvin; James J Lee; Nancy A Lee
Journal:  J Leukoc Biol       Date:  2017-05-17       Impact factor: 4.962

10.  Activated mouse eosinophils protect against lethal respiratory virus infection.

Authors:  Caroline M Percopo; Kimberly D Dyer; Sergei I Ochkur; Janice L Luo; Elizabeth R Fischer; James J Lee; Nancy A Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.